Association between Epstein-Barr virus and classic Hodgkin lymphoma in Jordan: a comparative study with Epstein-Barr virus-associated Hodgkin lymphoma in North America. 2004

Mohammad A Vasef, and Manaf A Ubaidat, and Hasan S Khalidi, and Nidal M Almasri, and Mousa Al-Abbadi, and Hassan Z Annab
Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA 52241, USA. mohammad-vasef@uiowa.edu

An association between Epstein-Barr virus and Hodgkin lymphoma has been shown in several parts of the world. The reported incidence of Epstein-Barr virus in Hodgkin lymphoma varies significantly from one country to another and ranges from <30% in Swedish patients to 100% in patients from Kenya. Using in situ hybridization for detection of Epstein-Barr virus-encoded RNA and immunohistochemistry for detection of Epstein-Barr virus latent membrane protein, we analyzed 28 cases of Hodgkin lymphoma from Jordan and 30 cases from the United States. Eight of 28 Jordanian cases and 9 of 30 North American cases were Epstein-Barr virus positive. Our studies show that the incidence of Epstein-Barr virus among Jordanian patients with Hodgkin lymphoma is similar to the rate in patients from the United States. This rate appears to be low to intermediate compared with rates in other parts of the world.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007597 Jordan A country in the MIDDLE EAST, northwest of Saudi Arabia, between Israel and Iraq. The capital is Amman.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009656 North America The northern continent of the Western Hemisphere, extending northward from the Colombia-Panama border and including CENTRAL AMERICA, MEXICO, Caribbean area, the UNITED STATES, CANADA and GREENLAND. The term often refers more narrowly to MEXICO, continental UNITED STATES, AND CANADA. Northern America
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006689 Hodgkin Disease A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen. Granuloma, Hodgkin,Granuloma, Malignant,Hodgkin Lymphoma,Lymphogranuloma, Malignant,Granuloma, Hodgkin's,Granuloma, Hodgkins,Hodgkin Lymphoma, Adult,Hodgkin's Disease,Hodgkin's Lymphoma,Hodgkins Disease,Lymphocyte Depletion Hodgkin's Lymphoma,Lymphocyte-Rich Classical Hodgkin's Lymphoma,Mixed Cellularity Hodgkin's Lymphoma,Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,Nodular Sclerosing Hodgkin's Lymphoma,Adult Hodgkin Lymphoma,Disease, Hodgkin,Disease, Hodgkin's,Disease, Hodgkins,Hodgkin Granuloma,Hodgkin's Granuloma,Hodgkins Granuloma,Hodgkins Lymphoma,Lymphocyte Rich Classical Hodgkin's Lymphoma,Lymphogranulomas, Malignant,Lymphoma, Hodgkin,Lymphoma, Hodgkin's,Malignant Granuloma,Malignant Granulomas,Malignant Lymphogranuloma,Malignant Lymphogranulomas,Nodular Lymphocyte Predominant Hodgkin's Lymphoma
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

Mohammad A Vasef, and Manaf A Ubaidat, and Hasan S Khalidi, and Nidal M Almasri, and Mousa Al-Abbadi, and Hassan Z Annab
June 2014, Hematology/oncology and stem cell therapy,
Mohammad A Vasef, and Manaf A Ubaidat, and Hasan S Khalidi, and Nidal M Almasri, and Mousa Al-Abbadi, and Hassan Z Annab
May 2018, Cancers,
Mohammad A Vasef, and Manaf A Ubaidat, and Hasan S Khalidi, and Nidal M Almasri, and Mousa Al-Abbadi, and Hassan Z Annab
July 2005, Orvosi hetilap,
Mohammad A Vasef, and Manaf A Ubaidat, and Hasan S Khalidi, and Nidal M Almasri, and Mousa Al-Abbadi, and Hassan Z Annab
January 2007, Hematology. American Society of Hematology. Education Program,
Mohammad A Vasef, and Manaf A Ubaidat, and Hasan S Khalidi, and Nidal M Almasri, and Mousa Al-Abbadi, and Hassan Z Annab
January 2024, iScience,
Mohammad A Vasef, and Manaf A Ubaidat, and Hasan S Khalidi, and Nidal M Almasri, and Mousa Al-Abbadi, and Hassan Z Annab
January 2019, Indian journal of pathology & microbiology,
Mohammad A Vasef, and Manaf A Ubaidat, and Hasan S Khalidi, and Nidal M Almasri, and Mousa Al-Abbadi, and Hassan Z Annab
May 1996, Journal of pediatric hematology/oncology,
Mohammad A Vasef, and Manaf A Ubaidat, and Hasan S Khalidi, and Nidal M Almasri, and Mousa Al-Abbadi, and Hassan Z Annab
January 2021, SAGE open medicine,
Mohammad A Vasef, and Manaf A Ubaidat, and Hasan S Khalidi, and Nidal M Almasri, and Mousa Al-Abbadi, and Hassan Z Annab
July 2019, Pediatric blood & cancer,
Mohammad A Vasef, and Manaf A Ubaidat, and Hasan S Khalidi, and Nidal M Almasri, and Mousa Al-Abbadi, and Hassan Z Annab
July 2021, Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion,
Copied contents to your clipboard!